Bank of Hawaii’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
6,839
+172
| +3% | +$31.7K | 0.07% | 112 |
|
|
2025
Q4 | $1.17M | Buy |
+6,667
| New | +$1.09M | 0.06% | 125 |
|
|
2023
Q3 | – | Sell |
-3,390
| Closed | -$966K | – | 237 |
|
|
2023
Q2 | $966K | Buy |
3,390
+29
| +0.9% | +$8.63K | 0.05% | 137 |
|
|
2023
Q1 | $934K | Buy |
3,361
+506
| +18% | +$140K | 0.05% | 142 |
|
|
2022
Q4 | $791K | Buy |
+2,855
| New | +$806K | 0.05% | 139 |
|
|
2020
Q2 | – | Sell |
-1,355
| Closed | -$429K | – | 290 |
|
|
2020
Q1 | $429K | Buy |
+1,355
| New | +$411K | 0.04% | 206 |
|
|
2019
Q1 | – | Sell |
-1,354
| Closed | -$407K | – | 312 |
|
|
2018
Q4 | $407K | Buy |
1,354
+305
| +29% | +$97.3K | 0.04% | 254 |
|
|
2018
Q3 | $371K | Buy |
+1,049
| New | +$361K | 0.03% | 278 |
|
|
2018
Q2 | – | Sell |
-1,782
| Closed | -$488K | – | 326 |
|
|
2018
Q1 | $488K | Buy |
1,782
+285
| +19% | +$88.5K | 0.04% | 241 |
|
|
2017
Q4 | $477K | Buy |
1,497
+205
| +16% | +$65.8K | 0.04% | 238 |
|
|
2017
Q3 | $405K | Sell |
1,292
-3
| -0.2% | -$888 | 0.03% | 250 |
|
|
2017
Q2 | $351K | Sell |
1,295
-10
| -0.8% | -$2.64K | 0.03% | 247 |
|
|
2017
Q1 | $357K | Sell |
1,305
-65
| -5% | -$18.4K | 0.03% | 244 |
|
|
2016
Q4 | $389K | Hold |
1,370
| – | – | 0.04% | 243 |
|
|
2016
Q3 | $429K | Buy |
+1,370
| New | +$406K | 0.04% | 238 |
|
|
2016
Q1 | – | Sell |
-697
| Closed | -$214K | – | 322 |
|
|
2015
Q4 | $214K | Sell |
697
-24
| -3% | -$6.9K | 0.02% | 347 |
|
|
2015
Q3 | $210K | Sell |
721
-1,250
| -63% | -$413K | 0.02% | 344 |
|
|
2015
Q2 | $796K | Sell |
1,971
-2,013
| -51% | -$808K | 0.08% | 191 |
|
|
2015
Q1 | $1.68M | Sell |
3,984
-230
| -5% | -$90.7K | 0.16% | 133 |
|
|
2014
Q4 | $1.43M | Hold |
4,214
| – | – | 0.13% | 144 |
|
|
2014
Q3 | $1.39M | Buy |
+4,214
| New | +$1.39M | 0.13% | 137 |
|
|
2014
Q2 | – | Sell |
-4,565
| Closed | -$1.4M | – | 351 |
|
|
2014
Q1 | $1.4M | Sell |
4,565
-1,070
| -19% | -$340K | 0.14% | 152 |
|
|
2013
Q4 | $1.57M | Buy |
5,635
+1,540
| +38% | +$398K | 0.16% | 138 |
|
|
2013
Q3 | $986K | Sell |
4,095
-140
| -3% | -$31.3K | 0.1% | 162 |
|
|
2013
Q2 | $911K | Buy |
+4,235
| New | +$905K | 0.1% | 164 |
|
Other funds holding BIIB
VCM
VPM
Bank of Hawaii's BIIB Position: Q1 2026 in Review
Bank of Hawaii increased its Biogen (BIIB) stake by 2.6% in Q1 2026, buying an estimated $31.7K and bringing the position to 6,839 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #112.
Bank of Hawaii first reported a position in BIIB in Q2 2013 and has held it in 25 quarters since. The position peaked at $1.68M in Q1 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Bank of Hawaii held 6,839 shares of Biogen worth $1.25M as of Q1 2026.
- Bank of Hawaii bought 172 Biogen shares in Q1 2026, an estimated $31.7K.
- Biogen made up 0.07% of Bank of Hawaii's portfolio in Q1 2026, its #112 holding.
- Bank of Hawaii first reported a position in Biogen in Q2 2013 and has held it in 25 quarters since.
- Bank of Hawaii's Biogen position peaked at $1.68M in Q1 2015.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Bank of Hawaii's 13F filing for Q1 2026, filed 15 May 2026.